Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  85,201,720 results for ""UNITED States""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

MINIstock: Model for INsect Inclusion in sustainable agriculture: USDA-ARS's research approach to advancing insect meal development and inclusion in animal diets.

Subjects: Animal Feed*/Animal Feed*/Animal Feed*/analysis ; Insecta* ; United States Department of Agriculture*

  • Source: Journal of economic entomology [J Econ Entomol] 2024 Aug 12; Vol. 117 (4), pp. 1199-1209.Publisher: Oxford University Press Country of Publication: England NLM ID: 2985127R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Understanding the Regulatory Pathways Used to Develop, Evaluate, Authorize, and Approve New Drugs and Vaccines in the United States.

  • Authors : Domachowske JB; Department of Pediatrics, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, New York 13210, USA.

Subjects: United States Food and Drug Administration* ; Drug Approval*/Drug Approval*/Drug Approval*/legislation & jurisprudence ; Vaccines*/Vaccines*/Vaccines*/therapeutic use

  • Source: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2024 Jul 12; Vol. 13 (Supplement_2), pp. S93-S102.Publisher: Oxford University Press Country of Publication: England NLM ID: 101586049 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency.

  • Authors : Kambere M; Office of Regulatory Affairs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, US.; Vu H

Subjects: United States Food and Drug Administration* ; COVID-19* ; Public Health*

  • Source: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Sep; Vol. 58 (5), pp. 987-995. Date of Electronic Publication: 2024 Jun 24.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

The Origins of "Confidential Commercial Information" at the FDA.

  • Authors : Daval CJR; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Kesselheim AS

Subjects: Confidentiality*/Confidentiality*/Confidentiality*/history ; Confidentiality*/Confidentiality*/Confidentiality*/legislation & jurisprudence ; Drug Industry*/Drug Industry*/Drug Industry*/history

  • Source: JAMA [JAMA] 2024 Aug 20; Vol. 332 (7), pp. 533-534.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

Read More Add to Saved list
×
Academic Journal

What We Know About Homeless Veterans With Other-than-honorable and Punitive Discharges: Data From the Grant and Per Diem (GPD) Program.

  • Authors : Jutkowitz E; Center of Innovation in Long Term Services and Supports, Providence VA Medical Center, Providence, RI 02908, USA.; Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, RI 02903, USA.

Subjects: Ill-Housed Persons*/Ill-Housed Persons*/Ill-Housed Persons*/statistics & numerical data ; Ill-Housed Persons*/Ill-Housed Persons*/Ill-Housed Persons*/psychology ; Veterans*/Veterans*/Veterans*/statistics & numerical data

  • Source: Military medicine [Mil Med] 2024 Jul 03; Vol. 189 (7-8), pp. e1443-e1449.Publisher: Oxford University Press Country of Publication: England NLM ID: 2984771R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of the Maintaining Internal Systems and Strengthening Integrated Outside Networks (MISSION) Act Scribes Trial on Emergency Department Provider Productivity and Patient Throughput Times.

  • Authors : Palani S; Partnered Evidence-based Policy Resource Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts; Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, Massachusetts. Electronic address: .

Subjects: Emergency Service, Hospital*/Emergency Service, Hospital*/Emergency Service, Hospital*/organization & administration ; Emergency Service, Hospital*/Emergency Service, Hospital*/Emergency Service, Hospital*/statistics & numerical data ; United States Department of Veterans Affairs*/United States Department of Veterans Affairs*/United States Department of Veterans Affairs*/organization & administration

  • Source: The Journal of emergency medicine [J Emerg Med] 2024 Jul; Vol. 67 (1), pp. e89-e98. Date of Electronic Publication: 2024 Mar 30.Publisher: Elsevier Country of Publication: United States NLM ID: 8412174 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective.

  • Authors : Jiang Y; Laboratory of Human Diseases and Immunotherapy, West China Hospital, Sichuan University, Chengdu 610041, China; Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China

Subjects: United States Food and Drug Administration* ; Drug Approval* ; Cardiovascular Agents*/Cardiovascular Agents*/Cardiovascular Agents*/chemistry

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 Sep 05; Vol. 275, pp. 116593. Date of Electronic Publication: 2024 Jun 15.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Report

Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System data: comment from Berkowitz et al.

  • Authors : Berkowitz C; Department of Medicine, Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; University of North Carolina Blood Research Center, Chapel Hill, North Carolina, USA.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; United States Food and Drug Administration*

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Sep; Vol. 22 (9), pp. 2674-2675.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print Cited Medium: Internet ISSN: 1538-7836

Record details

Read More Add to Saved list
×
Academic Journal

A Biologic With Otologic Consequences: Analysis of Hearing Loss and Teprotumumab Using the FDA Adverse Event Reporting System.

  • Authors : Huynh PP; Department of Head & Neck Surgery, Kaiser Permanente Oakland Medical Center.; Saba E

Subjects: Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; United States Food and Drug Administration* ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

  • Source: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology [Otol Neurotol] 2024 Sep Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100961504

Record details

Read More Add to Saved list
×
Academic Journal

FDA-approved small molecule kinase inhibitors for cancer treatment (2001-2015): Medical indication, structural optimization, and binding mode Part I.

  • Authors : Wang Y; Department of Electrophysiological Diagnosis, 3201 Hospital of Xi'an Jiaotong University Health Science Center, Hanzhong 723000, China.; Nan X

Subjects: Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/chemistry ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/pharmacology ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/chemical synthesis

  • Source: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Sep 01; Vol. 111, pp. 117870. Date of Electronic Publication: 2024 Aug 08.Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  85,201,720 results for ""UNITED States""